SUSAN S VANBEUGE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LAS VEGAS, NV NPI 1174501720
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NV Acerta Pharma LLC All categories
General Payments — all program years on this page
$10,433.07
- Category: General Payments
- Program years: PY2021–2024
- Record count: 61
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $845.19 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $845.19 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $218.27 | 2 |
| Abbott Laboratories | $142.12 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.55 | 1 |
| ARGENX US, INC. | $120.06 | 1 |
| Novo Nordisk AS | $119.47 | 1 |
| Ultragenyx Pharmaceutical Inc. | $102.36 | 1 |
| Daiichi Sankyo Inc. | $19.36 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089493924 | Daiichi Sankyo Inc. | $19.36 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100449107 | Novo Nordisk Inc | $119.47 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104704425 | AstraZeneca Pharmaceuticals LP | $121.96 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105231366 | AstraZeneca Pharmaceuticals LP | $96.31 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117901654 | Boehringer Ingelheim Pharmaceuticals, Inc. | $123.55 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124881282 | Abbott Laboratories | $142.12 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142151561 | ARGENX US, INC. | $120.06 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153279936 | Ultragenyx Pharmaceutical Inc. | $102.36 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.